Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome
Clinical trial NCT05982795 · RECRUITING
Trial details
- NCT number
- NCT05982795
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-08
- Primary completion
- 2026-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.